Joaquin Duato

Johnson & Johnson (NYSE: JNJ) announced recently a change in leadership with Alex Gorsky stepping down from his CEO role and handing the reigns to Joaquin Duato, who will take over on Jan. 3, 2022. Here are five things you might not know about Joaquin Duato, the next CEO of Johnson...

Biotech stocks swayed back and forth before ending the week lower. With earnings news dying down and an empty initial public offerings calendar, it was broader market cues, clinical readouts and regulatory actions that moved stocks during the week. Virpax Pharmaceuticals, Inc.(NASDAQ: VRPX)...